Clinical Hypertension

Resistant hypertension: consensus document from the Korean society of hypertension

Although reports vary, the prevalence of true resistant hypertension and apparent treatment-resistant hypertension (aTRH) has been reported to be 10.3% and 14.7%, respectively. As there is a rapid increase in the prevalence of obesity, chronic kidney disease, and diabetes mellitus, factors that are associated with resistant hypertension, the prevalence of resistant hypertension is expected to rise as well.

Sungha Park, Jinho Shin, Sang Hyun Ihm, Kwang-il Kim, Hack-Lyoung Kim, Hyeon Chang Kim, Eun Mi Lee, Jang Hoon Lee, Shin Young Ahn, Eun Joo Cho, Ju Han Kim, Hee-Taik Kang, Hae-Young Lee, Sunki Lee, Woohyeun Kim & Jong-Moo Park

Clinical Hypertension volume 29, Article number: 30 (2023)

Withdrawal of antihypertensive medication in young to middle-aged adults: a prospective, single-group, intervention study

Although antihypertensive drug therapy is commonly believed to be a life-long therapy, several recent guidelines have suggested that antihypertensive medications can be gradually reduced or discontinued for some patients whose blood pressure (BP) is well-controlled for an extended period. Thus, this pilot study aimed to describe the success rate of antihypertensive drug discontinuation over 6 months among young and middle-aged patients with hypertension.

Hae-Young Lee & Kyoung Suk Lee

Clinical Hypertension volume 29, Article number: 1 (2023) 

Prediction of cardiovascular events by central blood pressure using radial tonometry in type 2 diabetes mellitus patients

The study show the importance of CBP measurements in T2DM patients and present a cutoff value for ASCVD events and hypertension-induced complications.

Min-Sik Kim, Seon-Ah Cha & Gee-Hee Kim
Clinical Hypertension volume 28, Article number: 31 (2022) 

Affiliated with the Korean Society of Hypertension, Clinical Hypertension publishes in all areas of hypertension, pulmonary hypertension and vascular disorders including vascular biology, pharmacology, pediatric hypertension and imaging. Articles published in Clinical Hypertension also encompass other disciplines such as neuroscience, endocrinology, nephrology, rheumatology and nursing. Our expert Editorial Board welcomes submissions from across our subject area, and we pride ourselves on providing a swift editorial response.

Clinical Hypertension is the official journal of Korean Society of Hypertension (KSH).
KSH sponsors full amount of APC for all the articles accepted for publication so that the authors do not need to pay. 

All previous contents (1995-2014) from the Journal of the Korean Society of Hypertension are freely available at its official website.

Wook-Bum Pyun

Prof. PYUN is Professor of Medicine at Ewha Womans University, School of Medicine, Seoul Hospital, Seoul, Korea. He gained his MD degree at Yonsei University College of Medicine in Seoul, Korea and was awarded a PhD in medical science by Yonsei University. He had been served as deputy editor of Korean Circulation Journal, the official journal of Korean Society of Cardiology for more than 10 years and is immediate past president of Korean Society of Hypertension. His research interests primarily focus on blood pressure monitoring, cuff-less blood pressure measurement and renal denervation in difficult to control blood pressure

See the list of Editorial Board members.

We are pleased to announce that all articles published in Clinical Hypertension journal are covered and indexed in PubMed, PubMed Central, Web of Science (ESCI),  Scopus, EMBASE, Google Scholar, Proquest, KoreaMed, CAS and DOAJ.

In response to the growing need for revision of the hypertension treatment guideline, the Guideline Committee of the Korean Society of Hypertension have written their updated guidelines for the management of hypertension.